Insights into endometrial serous carcinogenesis and progression.
about
Uterine superficial serous carcinomas and extensive serous endometrial intraepithelial carcinomas: clinicopathological analysis of 6 patientsExpression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancerp53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibodyGene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.Type II endometrial cancers: A case series.Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1.Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions.Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment.p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
P2860
Q34732898-CE44D7E4-D1AF-4FC7-A5FA-F65B9BDCE2B9Q35730185-4013A1A6-16DE-4A5F-870C-BF34BB9B247BQ35915267-D8563AF5-6ACD-456F-B2F0-14C3AFA4F649Q36003197-9AA85185-EC05-4B8A-BC75-6AE5C7D8D55CQ36051697-B462D373-68D2-41AD-BA83-7F305CE94904Q36386468-F8B1E232-D219-43EA-BBE9-8400CFD9DCDAQ36949302-1577229D-7FB9-4CEC-96CF-CEE688B63E90Q37091852-2357435B-3055-424C-A6DC-BEE3C63A150DQ37126162-98F4537D-FEB6-433F-BD81-D8993F27AAFCQ37225495-9E7E3997-9DEC-4844-AAA8-4ECE48AD5F0AQ37412110-D63F2620-6E86-4CA9-90AA-3CD11806439DQ41875235-2A6A8A57-3CDE-4838-9C8F-B78664FAD723Q45395608-039A6628-4F8E-415F-82BD-B124DF537139
P2860
Insights into endometrial serous carcinogenesis and progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insights into endometrial serous carcinogenesis and progression.
@en
Insights into endometrial serous carcinogenesis and progression.
@nl
type
label
Insights into endometrial serous carcinogenesis and progression.
@en
Insights into endometrial serous carcinogenesis and progression.
@nl
prefLabel
Insights into endometrial serous carcinogenesis and progression.
@en
Insights into endometrial serous carcinogenesis and progression.
@nl
P2860
P1476
Insights into endometrial serous carcinogenesis and progression.
@en
P2093
Oluwole Fadare
Wenxin Zheng
P2860
P304
P577
2009-01-10T00:00:00Z